Tom McKillop

Sir Thomas Fulton Wilson McKillop, FRS, FRSE, FMedSci (born 19 March 1943) is a Scottish chemist, who was CEO of AstraZeneca PLC from 1999 until 2006 and chairman of the RBS Group from 2006 until 2008.

On 13 October 2008, British Prime Minister Gordon Brown announced a UK government bailout of £45 billion of new capital into Royal Bank of Scotland.

From the time that Goodwin took over as chief executive until 2007, RBS's assets quadrupled, its cost-to-income ratio improved markedly, and its profits soared.

[5] The deal was struck in October 2007 as the global liquidity crisis began to develop, with Barclays withdrawing its EUR61bn bid and ABN's shareholders endorsing the EUR71bn RBS takeover.

[4] Coming after the nationalisation of Northern Rock due to the freezing of the wholesale money markets, the deal proved the final straw for RBS, as it severely weakened its balance sheet not only through the size of the acquisition but due to ABN AMRO's substantial exposure to the US subprime mortgage crisis.

At a meeting of the Treasury Select Committee of the House of Commons on 10 February 2009, he admitted to having no qualifications in banking.